Literature DB >> 17169363

Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis.

Mustafa Caliskan1, Dogan Erdogan2, Hakan Gullu1, Sema Yilmaz3, Yusuf Gursoy1, Aylin Yildirir1, Eftal Yucel3, Haldun Muderrisoglu1.   

Abstract

BACKGROUND: It has been shown that the patients with inflammatory rheumatic diseases such as systemic lupus erythematosus and rheumatoid arthritis have an increased risk of developing atherosclerosis. However, the association of ankylosing spondylitis (AS) to atherosclerosis and related diseases is still controversial. Accordingly, we investigated coronary flow reserve (CFR) and left ventricular (LV) diastolic function in patients with AS using transthoracic Doppler echocardiography.
METHODS: CFR and LV diastolic function were studied in 40 patients with AS (38.9+/-10.2 years, 26 males) and 35 healthy volunteers (37.5+/-6.4 years, 23 males). Coronary diastolic peak flow velocities (DPFV) were measured at baseline and after dipyridamole infusion. CFR was calculated as the ratio of hyperemic to baseline DPFV. LV diastolic function was assessed by both standard and tissue Doppler imaging.
RESULTS: Demographic features and coronary risk factors except diastolic blood pressure were similar between the groups. CFR were significantly lower in the AS group than in the control group (2.20+/-0.46 versus 3.02+/-1.50, P<0.0001). Reflecting LV diastolic function mitral A-wave and E/A ratio were borderline significant, and mitral E-wave deceleration time and isovolumic relaxation time were significantly different between the groups. Serum hsCRP and TNF-alpha levels were significantly higher in the patients with AS, and hsCRP and TNF-alpha levels independently correlated with CFR.
CONCLUSION: These findings show that CFR reflecting coronary microvascular function and LV diastolic function are impaired in patients with AS, and severity of these impairments correlate well with hsCRP and TNF-alpha. These results suggest that impaired CFR may be an early manifestation of cardiac involvement in patients with AS.

Entities:  

Mesh:

Year:  2006        PMID: 17169363     DOI: 10.1016/j.atherosclerosis.2006.11.003

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  23 in total

Review 1.  Ankylosing spondylitis: A state of the art factual backbone.

Authors:  Mohammad Ghasemi-Rad; Hosam Attaya; Emal Lesha; Andrea Vegh; Tooraj Maleki-Miandoab; Emad Nosair; Nariman Sepehrvand; Ali Davarian; Hamid Rajebi; Abdolghader Pakniat; Seyed Amirhossein Fazeli; Afshin Mohammadi
Journal:  World J Radiol       Date:  2015-09-28

2.  Differences in cardiovascular manifestations between ankylosing spondylitis patients with and without kyphosis.

Authors:  Jun Fu; Manyan Wu; Yan Liang; Kai Song; Ming Ni; Yonggang Zhang; Jiying Chen
Journal:  Clin Rheumatol       Date:  2016-06-07       Impact factor: 2.980

Review 3.  Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis.

Authors:  V F Azevedo; R Pecoits-Filho
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

4.  Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade.

Authors:  Ashit Syngle; Kanchan Vohra; Anjali Sharma; L Kaur
Journal:  Clin Rheumatol       Date:  2010-03-05       Impact factor: 2.980

Review 5.  Echocardiography in the Assessment of Patients with Rheumatologic Diseases.

Authors:  Maha A Al-Mohaissen; Kwan-Leung Chan
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

6.  Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis.

Authors:  Nidhi Garg; Pawan Krishan; Ashit Syngle
Journal:  Clin Rheumatol       Date:  2015-03-17       Impact factor: 2.980

7.  Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis.

Authors:  Sadık Volkan Emren; Onay Gerçik; Emre Özdemir; Dilek Solmaz; Nihan Eren; Ersin Çağrı Şimşek; Mehmet Tokaç; Zeynep Emren; Gökhan Kabadayı; Servet Akar
Journal:  Eur J Rheumatol       Date:  2019-11-25

8.  Frequency of fragmented QRS in ankylosing spondylitis : a prospective controlled study.

Authors:  A Inanir; K Ceyhan; S Okan; H Kadi
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

Review 9.  Management of cardiovascular disease risk in chronic inflammatory disorders.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

Review 10.  Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights.

Authors:  Michael T Nurmohamed; Irene van der Horst-Bruinsma; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.